Attapulgite
This article was originally published in The Tan Sheet
Executive Summary
NDMA is scheduled to meet with FDA on July 1 to discuss a recommendation made by FDA's OTC and Gastrointestinal Drugs Advisory Committees on April 9 that attapulgite efficacy in treating diarrhea in adults is unproven ("The Tan Sheet" April 12, p. 1). NDMA expects to review some of the studies presented at the advisory committee meeting and to address follow-up issues and concerns.